Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Psychiatry Res. 2022 Jan 4;308:114387. doi: 10.1016/j.psychres.2022.114387

Table 2:

Psychosis Associated with Cannabis Use and Pacific vs. Other Census Divisions in the 2017 National (Nationwide) Inpatient Sample

Study Sample National Estimates
Pacific Census Division
N=479,071		 Other Census Divisions
N=2,979,171		 Pacific Census Division
N=2,395,348		 Other Census Divisions
N=14,895,853		 Unadjusted OR (95% CI) Adjusted OR* (95% CI)
Psychosis associated with Cannabis Use Hospitalizations, n (%) 4,502
(0.94)		 21,312
(0.72)		 22,510
(0.94)		 106,560
(0.72)		 1.32
(1.01, 1.72)		 1.55
(1.25, 1.93)
Other Hospitalizations (Not psychosis associated with cannabis use), n (%) 474,569
(99.1)		 2,957,859
(99.3)		 2,372,838
(99.1)		 14,789,293
(99.3)		 - -

OR = odds ratio, CI = confidence interval.

*

Adjusted for age, sex, race, income quartile, hospital location, alcohol use disorders, other substance use disorders, smoking, depression/anxiety, post-traumatic stress disorder, other psychiatric disorders, arthritis, cancer, HIV/AIDS, multiple sclerosis, Parkinson’s disease, epilepsy, nausea/vomiting, cachexia, glaucoma, inflammatory bowel disease and chronic pain. Survey methods were used to derive weighted percentages and standard errors.